This report contains market size and forecasts of Actonel (Risedronic Acid) ( CAS 105462-24-6) in global, including the following market information:
Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Actonel (Risedronic Acid) ( CAS 105462-24-6) companies in 2021 (%)
The global Actonel (Risedronic Acid) ( CAS 105462-24-6) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Actonel (Risedronic Acid) ( CAS 105462-24-6) include Allergan plc (AbbVie Inc.), Takeda, Apotex, Warner Chilcott, Teva Pharmaceutical Industries, Mylan, Macleods Pharmaceuticals Ltd, Aurobindo Pharma and Sun Pharmaceutical Industries Ltd.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Actonel (Risedronic Acid) ( CAS 105462-24-6) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Segment Percentages, by Type, 2021 (%)
5 mg
35 mg
75 mg
150 mg
Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Segment Percentages, by Application, 2021 (%)
Osteoporosis
Paget's Disease of Bone
Others
Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Actonel (Risedronic Acid) ( CAS 105462-24-6) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Actonel (Risedronic Acid) ( CAS 105462-24-6) revenues share in global market, 2021 (%)
Key companies Actonel (Risedronic Acid) ( CAS 105462-24-6) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Actonel (Risedronic Acid) ( CAS 105462-24-6) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan plc (AbbVie Inc.)
Takeda
Apotex
Warner Chilcott
Teva Pharmaceutical Industries
Mylan
Macleods Pharmaceuticals Ltd
Aurobindo Pharma
Sun Pharmaceutical Industries Ltd.